Published October 26, 2020
| Version v1
Journal article
Penile cancer: a Brazilian consensus statement for low- and middle-income countries
Creators
- Soares, Andrey1, 2, 3
- De Carvalho, Icaro Thiago4, 5
- Da Fonseca, Aluízio Gonçalves6
- Alencar, Antonio Machado Jr.7, 8
- Leite, Carlos Heli Bezerra9
- Bastos, Diogo Assed10, 1
- Soares, João Paulo Holanda11
- Leite, Katia Ramos Moreira12
- Filho, Mário Ronalsa Brandão13
- Coelho, Ronald Wagner Pereira14, 1
- and others
- 1. Latin American Cooperative Oncology Group (Brazil)
- 2. Hospital Israelita Albert Einstein. Department of Oncology (Brazil)
- 3. Centro Paulista de Oncologia-Oncoclínicas. Department of Oncology (Brazil)
- 4. Instituto Abathon (Brazil)
- 5. Hospital Israelita Albert Einstein. Department of Radiotherapy (Brazil)
- 6. Hospital Ophir Loyola. Department of Urology (Brazil)
- 7. Hospital São Domingos. Department of Oncology (Brazil)
- 8. Hospital Universitário da Universidade Federal do Maranhão. Department of Oncology (Brazil)
- 9. Hospital Haroldo Juaçaba. Department of Radiotherapy (Brazil)
- 10. Hospital Sírio-Libanês. Department of Oncology (Brazil)
- 11. Hospital Haroldo Juaçaba. Department of Oncology (Brazil)
- 12. Medical Research Laboratory of the Discipline of Urology, Faculdade de Medicina da USP (Brazil)
- 13. Santa Casa de Misericórdia de Maceió. Department of Urology (Brazil)
- 14. Hospital do Câncer Aldenora Bello. Department of Oncology (Brazil)
Description
Purpose
: Penile cancer is highly prevalent in low- and middle-income countries, with significant morbidity and mortality rates. The first Brazilian consensus provides support to improve penile cancer patients' outcomes, based on expert's opinion and evidence from medical literature.Methods
: Fifty-one Brazilian experts (clinical oncologists, radiation oncologists, urologists, and pathologists) assembled and voted 104 multiple-choice questions, confronted the results with the literature, and ranked the levels of evidence.Results
: Healthcare professionals need to deliver more effective communication about the risk factors for penile cancer. Staging and follow-up of patients include physical examination, computed tomography, and magnetic resonance imaging. Close monitoring is crucial, because most recurrences occur in the first 2–5 years. Lymph-node involvement is the most important predictive factor for survival, and management depends on the location (inguinal or pelvic) and the number of lymph nodes involved. Conservative treatment may be helpful in selected patients without compromising oncological outcomes; however, surgery yields the lowest rate of local recurrence.Conclusion
: This consensus provides an essential decision-making orientation regarding this challenging disease.Additional details
Identifiers
Publishing Information
- Journal Title
- Journal of Cancer Research and Clinical Oncology
- Journal Volume
- 146
- Journal Issue
- 12
- Journal Page Range
- p. 3281-3296
- ISSN
- 0171-5216
- CODEN
- JCROD7
INIS
- Country of Publication
- Germany
- Country of Input or Organization
- International Atomic Energy Agency (IAEA)
- INIS RN
- 55071817
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- BRAZIL; COMMUNICATIONS; COMPUTERIZED TOMOGRAPHY; DECISION MAKING; DISEASE INCIDENCE; HAZARDS; LYMPH NODES; MEDICAL PERSONNEL; MORTALITY; NEOPLASMS; NMR IMAGING; PATIENTS; PELVIS; SURGERY; SURVIVAL CURVES
- Descriptors DEC
- BODY; DEVELOPING COUNTRIES; DIAGNOSTIC TECHNIQUES; DISEASES; LATIN AMERICA; LYMPHATIC SYSTEM; MEDICINE; PERSONNEL; SOUTH AMERICA; TOMOGRAPHY
Optional Information
- Copyright
- Copyright (c) 2020 © The Author(s) 2020